← Back to Clinical Trials
Recruiting NCT06242366

NCT06242366 Transitional Care Program in Stroke Patients With Hemiplegia.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06242366
Status Recruiting
Phase
Sponsor Mahidol University
Condition Ischemic Stroke
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-02-07
Primary Completion 2025-07-01

Trial Parameters

Condition Ischemic Stroke
Sponsor Mahidol University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-02-07
Completion 2025-07-01
Interventions
Intervention group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study examines the effects of a transitional care program in stroke patients on self-care behavior, quality of life, and hospital readmission. The research conceptual framework is based on the Transitional Care Model by Naylor. Sixty participants with stroke patients at Charoenkrung Pracharak Hospital will be recruited. These participants are stratified by block randomization using NIHSS score and divided into 2 groups; a control group (n=30) and an intervention group (n=30). The program consisted of 2 phases: 1) Phase I during hospital admission and 2) Phase II following hospital discharge

Eligibility Criteria

Inclusion Criteria: * Age from 18 years old. * The first diagnosis is acute ischemic stroke. * Hemiplegia * NIHSS 5-14 point (moderate impairment) * Telephone and Line Application used. * Can read and communicate in Thai language * Accept participants to research and inform consent. Exclusion Criteria: * Aphasia * The Six Item Cognitive Impairment Test: 6CIT from 8 points in age from 60 years old. * Participants with illness severity or dead during the study. * Reject the study

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology